MedPath

A clinical study of zinc supplementation in children with fast breathing and breathing difficulty

Not Applicable
Completed
Registration Number
CTRI/2009/091/000040
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children aged 2-24 months presenting with tachypnoea and either chest retractions or one of the following danger signs: cyanosis, inability to feed/drink, lethargy and convulsions

Exclusion Criteria

Children with concurrent diarrhea, severe malnutrition (weight for age <50% of reference value), congenital heart disease and those already on zinc supplements were excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to be asymptomaticTimepoint: defined as resolution of all four of the following: respiratory distress, tachypnoea, hypoxia in room air and systemic danger signs
Secondary Outcome Measures
NameTimeMethod
Duration of hospital stayTimepoint: measured at discharge from hospital
© Copyright 2025. All Rights Reserved by MedPath